Skip to main content

Table 2 Characteristics of patients included in the LE skin biopsies: cumulative ACR criteria, autoantibody specificities, and medication

From: Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?

Patient characteristics

SBC/co-loc

No.

Gender

Age

    

A

C

R

    

Prednisone

Hydroxychloroquine

Azathioprine

Autoantibody

   

(Years)

1

2

3

4

5

6

7

8

9

10

11

(mg/day)

(mg/day)

(mg/day)

specificities

+/+

1

F

45

-

-

-

-

-

+

+

-

-

+

+

 

-

75

SSA/SSB/dsDNA

+/+

2

F

51

+

-

+

-

-

+

-

-

+

-

+

5

-

100

SSA/SSB

+/+

3

F

70

-

+

-

-

-

-

-

-

+

+

+

10

200

25

Sm/SSA/nRNP

-/-

4

M

47

-

+

+

-

-

-

-

-

+

 

+

-

-

-

SSA/SSB

-/-

5

F

45

+

+

-

+

+

-

-

-

+

+

+

-

5

-

Sm/nRNP/CL

+/-

6

F

50

+

+

-

+

+

-

-

-

+

+

+

12.5

600

-

Sm/nRNP/CL

+/+

7

F

49

+

+

-

+

+

-

-

-

+

+

+

10

600

-

Sm/nRNP/CL

+/-

8

F

39

+

-

+

+

+

-

-

-

-

+

+

60

-

-

dsDNA

+/+

9

F

41

+

-

-

-

+

+

-

-

-

+

+

2.5

-

75

SSA/SSB/dsDNA

+/+

10

F

45

-

+

-

-

+

+

+

-

+

+

+

5

400

-

dsDNA

+/+

11

F

46

-

+

-

-

+

+

+

-

+

+

+

5

400

-

dsDNA

+/-

12

F

38

-

+

-

-

+

-

-

-

-

+

+

-

-

-

dsDNA

-/-

13

F

75

-

-

-

-

+

-

-

-

+

+

+

-

-

-

dsDNA/CL

+/-

14

F

33

+

-

-

-

+

-

-

-

+

+

+

-

-

-

SSA/Sm/nRNP/dsDNA

+/+

15

F

58

-

+

+

-

-

-

-

-

+

+

+

-

-

-

SSA/dsDNA

+/-

16

F

38

-

+

+

-

-

-

-

-

+

+

+

-

-

-

SSA/dsDNA

-/-

17

F

49

-

+

+

-

-

-

+

-

+

-

+

-

800

-

dsDNA/CL

+/+

18

F

49

-

+

-

+

+

+

-

-

+

+

+

7.5

-

-

dsDNA

+/+

19

M

35

-

+

+

-

-

-

-

-

 

+

+

-

-

-

SSA/dsDNA

+/-

20

F

26

+

-

+

-

-

-

-

-

+

+

+

-

-

-

nRNP/Sm/dsDNA

  1. ACR criteria numbered according to Bombardier et al. [19]: 1, malar (or 'butterfly') rash; 2, discoid rash; 3, sensitivity to light, or photosensitivity; 4, oral ulcers; 5, arthritis; 6, serositis; 7, kidney disorder; 8, neurologic disorder; 9, blood abnormalities; 10, positive antiphospholipid antibody test; 11, immunologic disorder, including lupus anticoagulant, positive anti-double-stranded DNA, false-positive syphilis test, or positive anti-Smith test (such as anticardiolipin). + and - indicate cumulative presence or absence, respectively, of a particular criterion. In the leftmost column, +/- indicates biopsies containing SBCs but no apparent co-localisation, +/+ indicates biopsies containing co-localisation of inflammatory lesions and SBCs, and - indicates biopsies without SBCs. ACR, American College of Rheumatology; co-loc, co-localisation; F, female, LE, lupus erythematosus; M, male; SBC, sunburn cell; UVB, ultraviolet B light.